SCHEMBL25841010

SCHEMBL25841010

Cc1ccc2c(c1)OC(F)(P)O2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.34
ATM Q13315 2/20 0.34
RAD52 P43351 1/20 0.34
MMP12 P39900 1/20 0.33
HTT P42858 2/20 0.33
CYP1A2 P05177 2/20 0.32
CYP2A6 P11509 2/20 0.32
ALDH1A1 P00352 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TSHR P16473 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA4 P22748 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
BRD4 O60885 1/20 0.30
CREBBP Q92793 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21583090 1.00 KDM4E (0.34) KDM4EATMRAD52MMP12HTT
SCHEMBL14819 0.83 CTNNB1 (0.41) KDM4EATMRAD52MMP12
SCHEMBL423132 0.83 KIF11 (0.40) KDM4EATMRAD52MMP12HTT
SCHEMBL26314085 0.81 TSHR (0.37) KDM4EATMRAD52MMP12HTT
SCHEMBL2666085 0.81 TSHR (0.37) KDM4EATMRAD52MMP12HTT
SCHEMBL9062743 0.76 MMP12 (0.35) KDM4EATMRAD52MMP12HTT
SCHEMBL8167005 0.76 TSHR (0.59) KDM4EATMMMP12HTTCYP1A2
SCHEMBL15869808 0.76 KDM4E (0.43) KDM4EATMRAD52MMP12HTT
SCHEMBL4944753 0.75 KIF11 (0.36) KDM4EATMRAD52MMP12HTT
SCHEMBL10920833 0.74 MMP12 (0.35) KDM4EATMRAD52MMP12HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227438-A1 AZASPIROCYCLES AS MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227438-A1 AZASPIROCYCLES AS MONOACYLGLYCEROL LIPASE MODULATORS MGLL, LPAR1, LPL KDM4E 2026/4885ATM 4069/4885RAD52 2130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.